MYC expression mediated resistance to AZD8186 treatment, indicating an essential role of the transcription factor for the survival-promoting effect of the PI3K signaling pathway in GCB DLBCL (Supplementary Fig. 5b). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.